KingKitty Posted June 18, 2022 Share Posted June 18, 2022 On 6/17/2022 at 1:02 AM, Macnamara said: Same drugs used to chemically castrate pedophiles now being handed out to children to make them “trans” 06/12/2022 / By Ethan Huff Many people are unaware of this, but the pharmaceutical cocktails that “doctors” are now prescribing to children in order to turn them “transgender” are the same ones that the criminal justice system punishes pedophiles with in order to chemically castrate them. Lupron (leuprolide acetate), a gonadotropin-releasing hormone agonist, is one of the drugs of choice for “trans” kids to make them become their “real selves.” We are told that the puberty blocker is safe and effective for this off-label use because it is supposedly “temporary.” The Mayo Clinic says Lupron helps transgender and “gender-diverse” children to achieve their trans goals, calling it a “big step.” What the Minnesota-based health care provider does not say, however, is that pedophiles have been getting Lupron forever – and the effects are permanent. “In those identified as male at birth, GnRH analogs decrease the growth of facial and body hair, prevent voice deepening, and limit the growth of genitalia,” the Mayo Clinic adds. “In those identified as female at birth, treatment limits or stops breast development and stops menstruation” (Related: Thousands of children have died from taking Lupron). https://www.newstarget.com/2022-06-12-same-drugs-chemically-castrate-pedophiles-children-trans.html From the Harry Benjamin Standards of Care. Potential Negative Medical Side Effects: Patients with medical problems or otherwise at risk for cardiovascular disease may be more likely to experience serious or fatal consequences of cross-sex hormonal treatments. For example, cigarette smoking, obesity, advanced age, heart disease, hypertension, clotting abnormalities, malignancy, and some endocrine abnormalities may increase side effects and risks for hormonal treatment. Therefore, some patients may not be able to tolerate cross-sex hormones. However, hormones can provide health benefits as well as risks. Risk-benefit ratios should be considered collaboratively by the patient and prescribing physician. Side effects in biologic males treated with estrogens and progestins may include increased propensity to blood clotting (venous thrombosis with a risk of fatal pulmonary embolism), development of benign pituitary prolactinomas, infertility, weight gain, emotional lability, liver disease, gallston formation, somnolence, hypertension, and diabetes mellitus. Side effects in biologic females treated with testosterone may include infertility, acne, emotional lability, increases in sexual desire, shift of lipid profiles to male patterns which increase the risk of cardiovascular disease, and the potential to develop benign and malignant liver tumors and hepatic dysfunction. The Differences between Eligibility and Readiness: The SOC provide recommendations for eligibility requirements for hormones and surgery. Without first meeting these recommended eligibility requirements, the patient and the therapist should not request hormones or surgery. An example of an eligibility requirement is: a person must live full time in the preferred gender for twelve months prior to genital surgery. To meet this criterion, the professional needs to document that the real life experience has occurred for this duration. Meeting readiness criteria -- further consolidation of the evolving gender identity or improving mental health in the new or confirmed gender role -- is more complicated, because it rests upon the clinician's and the patient’s judgment. The Mental Health Professional's Relationship to the Prescribing Physician and Surgeon. Mental health professionals who recommend hormonal and surgical therapy share the legal and ethical responsibility for that decision with the physician who undertakes the treatment. Hormonal treatment can often alleviate anxiety and depression in people without the use of additional psychotropic medications. Some individuals, however, need psychotropic medication prior to, or concurrent with, taking hormones or having surgery. The mental health professional is expected to make this assessment, and see that the appropriate psychotropic medications are offered to the patient. The presence of psychiatric co-morbidities does not necessarily preclude hormonal or surgical treatment, but some diagnoses pose difficult treatment dilemmas and may delay or preclude the use of either treatment. 2 Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.